S. Larney

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S Larney, S. Larney, Sarah Larney
Publication record
192 papers · 9,140 citations · H-index 43

PAPERS

Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studies
20251 citationsauthor #7
Population Aging and Apparent Decline in Initiation of Injecting Drug Use in Australia
20250 citationsauthor #7
The Impact of Severe Mental Illness on Treatment Retention and All-Cause Mortality of Individuals in Opioid Agonist Treatment: A Retrospective Data Linkage Study
20250 citationsauthor #7
Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence
20240 citationsauthor #5
All‐cause and cause‐specific mortality in individuals with an alcohol‐related emergency or hospital inpatient presentation: A retrospective data linkage cohort study
20235 citationsauthor #9
Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
20235 citationsauthor #9
High risk of death from multiple causes following release from incarceration: an individual participant data meta-analysis of 1,471526 adults in eight countries
20230 citationsauthor #7
Prevalence of opioid dependence in New South Wales, Australia, 2014-16: Indirect estimation from multiple data sources using a Bayesian approach.
202313 citationsauthor #4
Universal hepatitis C virus screening and treatment as part of prenatal care.
20234 citationsauthor #5
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-2017.
202313 citationsauthor #1
Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality.
20237 citationsauthor #5
Associations between the prevalence of chronic hepatitis B among people who inject drugs and country‐level characteristics: An ecological analysis
20235 citationsauthor #6
Five-Year Trajectories of Prescription Opioid Use
202316 citationsauthor #8
The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review
20235 citationsauthor #3
HCV treatment initiation in the era of universal direct acting antiviral coverage - Improvements in access and persistent barriers.
20237 citationsauthor #7
Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?
20220 citationsauthor #2
A gender lens is needed in hepatitis C elimination research.
202217 citationsauthor #1
Trends in opioid analgesic utilisation among people with a history of opioid dependence.
20223 citationsauthor #5
Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.
20225 citationsauthor #3
Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005-2019.
202218 citationsauthor #7
Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times
202218 citationsauthor #4
The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study.
202228 citationsauthor #3
Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada
202220 citationsauthor #6
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study
202212 citationsauthor #9
Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map
202224 citationsauthor #6
Association Between Markers of Vulnerability for Cannabis-Related Harms and Source of Supply: Secondary Analysis of a Representative Population Survey
20221 citationsauthor #4
Changes in Youth Mental Health, Psychological Wellbeing, and Substance Use During the COVID-19 Pandemic: A Rapid Review
2021122 citationsauthor #9
535The epidemiology of all-cause and cause-specific mortality following release from prison in 11 countries
20210 citationsauthor #6
Modelling the impact of opioid agonist treatment upon multiple mortality outcomes in people who inject drugs: a three-setting analysis
20210 citationsauthor #4
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis.
202129 citationsauthor #4
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study.
202122 citationsauthor #2
Association between supply source and vulnerability markers to cannabis-related harms: a cross-sectional study
20210 citationsauthor #5
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
202141 citationsauthor #7
Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment.
20219 citationsauthor #4
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
202122 citationsauthor #6
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system.
202118 citationsauthor #4
Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia.
20215 citationsauthor #4
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19
202176 citationsauthor #8
The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalisations: a Bayesian analysis of treated patients and matched controls.
20215 citationsauthor #3
Mapping drug epidemiology futures.
20217 citationsauthor #1
Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy.
20204 citationsauthor #2
Using Linked Data to Examine the Epidemiology of All-Cause and Cause-Specific Mortality Following Release from Incarceration in Eleven Countries
20200 citationsauthor #7
Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review.
20204 citationsauthor #10
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis.
202033 citationsauthor #7
Data resource profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia.
202015 citationsauthor #1
Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia.
202026 citationsauthor #2
The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas
202021 citationsauthor #4
Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis.
202065 citationsauthor #6
All-Cause and Overdose Mortality Risk Among People Prescribed Opioids: A Systematic Review and Meta-analysis.
202012 citationsauthor #1
Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes.
202022 citationsauthor #6
Global opioid agonist treatment: A review of clinical practices by country.
202071 citationsauthor #2
Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study.
202019 citationsauthor #6
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence.
202027 citationsauthor #1
What predicts pharmacists’ engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy
20208 citationsauthor #7
Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia.
20207 citationsauthor #9
All-cause and cause-specific mortality among people with regular or problematic cocaine use: A systematic review and meta-analysis.
202029 citationsauthor #3
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
202014 citationsauthor #8
Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysis.
20207 citationsauthor #4
Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort study.
202010 citationsauthor #3
The contribution of injecting drug use as a risk factor for Hepatitis C virus transmission globally, regionally, and at country level: a modelling study
20198 citationsauthor #9
Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis.
201958 citationsauthor #2
Frequency of health‐care utilization by adults who use illicit drugs: a systematic review and meta‐analysis
2019138 citationsauthor #4
The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
201935 citationsauthor #3
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.
2019196 citationsauthor #9
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
201942 citationsauthor #16
Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia.
20193 citationsauthor #8
Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
201925 citationsauthor #2
Perceptions of extended-release buprenorphine injections for opioid dependence prior to availability in Australia: a cross-sectional survey of people who use opioids regularly
20190 citationsauthor #8
Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
201916 citationsauthor #4
Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.
201951 citationsauthor #5
CHARACTERISING PEOPLE ATTENDING NEW SOUTH WALES EMERGENCY DEPARTMENTS AND HOSPITALS FOR AN ALCOHOL-RELATED PROBLEM, 2005-2014: THE DATA-LINKAGE ALCOHOL COHORT STUDY
20190 citationsauthor #5
Modelling the potential prevention benefits of a treat‐all hepatitis C treatment strategy at global, regional and country levels: A modelling study
201916 citationsauthor #9
A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA.
201911 citationsauthor #1
Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.
201910 citationsauthor #7
MORTALITY IN PEOPLE WHO USE OPIOIDS: SYSTEMATIC REVIEW AND META-ANALYSIS
20190 citationsauthor #7
Global patterns of opioid use and dependence: harms to populations, interventions, and future action.
2019594 citationsauthor #11
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
201961 citationsauthor #2
Mortality in people who use stimulants: systematic review and meta-analysis
20190 citationsauthor #4
Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
201963 citationsauthor #8
Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data
201910 citationsauthor #5
Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.
201932 citationsauthor #3
Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis
201926 citationsauthor #4
All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids: A Systematic Review and Meta-analysis.
2019121 citationsauthor #1
The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis.
201993 citationsauthor #4
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
2018235 citationsauthor #2
Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health‐care system
201824 citationsauthor #2
Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence.
201824 citationsauthor #6
Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release [Drug and Alcohol Dependence 184 (2018) 57-63].
20183 citationsauthor #4
To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia?
201846 citationsauthor #6
A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
201884 citationsauthor #4
Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world.
20180 citationsauthor #2
Comparing the prevention gains of different treatment strategies at the global, regional, and country level: a modelling study
20180 citationsauthor #9
A population-based study of transdermal fentanyl initiation in Australian clinical practice
20189 citationsauthor #4
Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical Claims
20187 citationsauthor #8
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
2018878 citationsauthor #3
The contribution of injecting drug use to Hepatitis C virus transmission globally, regionally, and at country level: a modelling study
20181 citationsauthor #9
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
201828 citationsauthor #1
Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012
201827 citationsauthor #5
Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.
201858 citationsauthor #7
Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?
201813 citationsauthor #2

TIMELINE

2007 7 citations

2008 34 citations

2009 154 citations

2010 157 citations

2011 49 citations

2012 265 citations

2013 529 citations

2014 482 citations

2015 748 citations

2016 567 citations

2017 2,087 citations

2018 1,488 citations

2019 1,609 citations

2020 394 citations

2021 356 citations

2022 146 citations

2023 80 citations

2024 0 citations

2025 1 citations

S. Larney

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT